Prior Auth Required

0174U - benefit of 39 chemotherapy and targeted therapeutic oncology agents

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicebenefit of 39 chemotherapy and targeted therapeutic oncology agents
Procedure / Service Description

Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic - Oncology (solid tumor), mass spectrometric 30 protein targets, formalin-fixed paraffin- embedded tissue, prognostic and predictive algorithm reported as likely, unlikely, or uncertain 0174U benefit of 39 chemotherapy and targeted therapeutic oncology agents 0175U Psychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genes 0176U Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.